Literature DB >> 22959303

New insights into cell cycle regulation and DNA damage response in embryonic stem cells.

Irina I Suvorova1, Natalia V Katolikova, Valery A Pospelov.   

Abstract

Embryonic stem cells (ESCs) have unlimited proliferative potential, while retaining the ability to differentiate into descendants of all three embryonic layers. High proliferation rate of ESCs is accompanied by a shortening of the G(1) phase and the lack of G(1) checkpoint following DNA damage. The absence of G(1) arrest in ESCs after DNA damage is likely caused by a dysfunction of the p53-dependent p21Waf1 pathway that is a key event for the maintenance of pluripotency. There are controversial data on the functional status of p53, but it is well established that one of the key p53 target-p21Waf1-is expressed in ESCs at a very low level. Despite the lack of G(1) checkpoint, ESCs are capable to repair DNA defects; moreover the DNA damage response (DDR) signaling operates very effectively throughout the cell cycle. This review covers also the results obtained with the reprogramming of somatic cells into the induced pluripotent stem cells, for which have been shown that a partial dysfunction of the p53Waf1 pathway increases the frequency of generation of pluripotent cells. In summary, these results indicate that the G(1) checkpoint control and DDR are distinct from somatic cells and their status is tightly connected with maintaining of pluripotency and self-renewal.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959303     DOI: 10.1016/B978-0-12-394310-1.00004-7

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  3 in total

1.  G1 checkpoint is compromised in mouse ESCs due to functional uncoupling of p53-p21Waf1 signaling.

Authors:  Irina I Suvorova; Bogdan B Grigorash; Ilya A Chuykin; Tatiana V Pospelova; Valery A Pospelov
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Effectiveness of gene delivery systems for pluripotent and differentiated cells.

Authors:  Kleopatra Rapti; Francesca Stillitano; Ioannis Karakikes; Mathieu Nonnenmacher; Thomas Weber; Jean-Sebastian Hulot; Roger J Hajjar
Journal:  Mol Ther Methods Clin Dev       Date:  2015-02-18       Impact factor: 6.698

3.  Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.

Authors:  Erika A Newman; Sahiti Chukkapalli; Daniela Bashllari; Tina T Thomas; Raelene A Van Noord; Elizabeth R Lawlor; Mark J Hoenerhoff; Anthony W Opipari; Valerie P Opipari
Journal:  Cell Death Dis       Date:  2017-12-13       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.